SPY415.21-2.05 -0.49%
DIA340.75-1.11 -0.32%
IXIC13,914.77-137.58 -0.98%

BRIEF-Amathus Therapeutics Signs Strategic Collaboration With Merck To Develop Treatments For Neurodegenerative Diseases

· 03/17/2021 08:07
BRIEF-Amathus Therapeutics Signs Strategic Collaboration With Merck To Develop Treatments For Neurodegenerative Diseases

- Merck & Co Inc MRK.N:

  • AMATHUS THERAPEUTICS SIGNS STRATEGIC COLLABORATION WITH MERCK TO DEVELOP TREATMENTS FOR NEURODEGENERATIVE DISEASES

Source text for Eikon: ID:nBw3vYJw0a

Further company coverage: MRK.N


((Reuters.Briefs@thomsonreuters.com;))